Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC

被引：4
|
作者：
De Jong, E. E. C. [1 ]
Van Elmpt, W. [1 ]
Hendriks, L. E. L. [2 ]
Leijenaar, R. T. H. [1 ]
Dingemans, A. M. C. [2 ]
Lambin, P. [1 ]
机构：
[1] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol,MAASTRO Clin, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pulmonol, Maastricht, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31859-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0609
引用
收藏
页码：S290 / S291
页数：2
相关论文
共 50 条
  • [1] PET/CT Radiomic Sequencer for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients
    Shiri, I
    Maleki, H.
    Hajianfar, G.
    Abdollahi, H.
    Ashrafinia, S.
    Oghli, M. G.
    Hatt, M.
    Oveisi, M.
    Rahmim, A.
    [J]. 2018 IEEE NUCLEAR SCIENCE SYMPOSIUM AND MEDICAL IMAGING CONFERENCE PROCEEDINGS (NSS/MIC), 2018,
  • [2] Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
    Digumarthy, Subba R.
    Padole, Atul M.
    Lo Gullo, Roberto
    Sequist, Lecia V.
    Kalra, Mannudeep K.
    [J]. MEDICINE, 2019, 98 (01) : E13963
  • [3] PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs
    Yang, Liping
    Xu, Panpan
    Li, Mengyue
    Wang, Menglu
    Peng, Mengye
    Zhang, Ying
    Wu, Tingting
    Chu, Wenjie
    Wang, Kezheng
    Meng, Hongxue
    Zhang, Lingbo
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Prediction of EGFR mutation status through radiomic features from 18F FDG PET/CT in NSCLC cohort of patients
    Monaco, L.
    De Bernardi, E.
    Bertola, F.
    Bono, F.
    Casati, G.
    Cortinovis, D.
    Crivellaro, C.
    Elisei, F.
    L'Imperio, V.
    Landoni, C.
    Pagni, F.
    Turolla, E.
    Messa, C.
    Guerra, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S468 - S468
  • [5] In advanced NSCLC EGFR Mutation Status test
    Schuette, Wolfgang
    [J]. ONKOLOGIE, 2012, 35 (06): : 393 - 393
  • [6] Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
    Liu, Ying
    Kim, Jongphil
    Balagurunathan, Yoganand
    Li, Qian
    Garcia, Alberto L.
    Stringfield, Olya
    Ye, Zhaoxiang
    Gillies, Robert J.
    [J]. CLINICAL LUNG CANCER, 2016, 17 (05) : 441 - 448
  • [7] Prognostic Implications of KRAS Mutation Status and KRAS Mutation Type in Patients With Advanced NSCLC Treated With Cytotoxic Chemotherapy
    Iams, W. T.
    Hames, M. L.
    Chen, H.
    Aston, J. L.
    Horn, L.
    Lovly, C. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S42 - S42
  • [8] Evaluation of concurrent chemoradiotherapy for locally advanced NSCLC according to EGFR mutation status
    Ishihara, Mikiko
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Fukui, Tomoya
    Ryuge, Shinichiro
    Katono, Ken
    Hiyoshi, Yasuhiro
    Kasajima, Masashi
    Mitsufuji, Hisashi
    Kubota, Masaru
    Yokoba, Masanori
    Katagiri, Masato
    Sekiguchi, Akane
    Soda, Itaru
    Ishiyama, Hiromichi
    Hayakawa, Kazushige
    Masuda, Noriyuki
    [J]. ONCOLOGY LETTERS, 2017, 14 (01) : 885 - 890
  • [9] PET/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features
    Huang, Weicheng
    Wang, Jingyi
    Wang, Haolin
    Zhang, Yuxiang
    Zhao, Fengjun
    Li, Kang
    Su, Linzhi
    Kang, Fei
    Cao, Xin
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Establishment and Evaluation of EGFR Mutation Prediction Model Based on Tumor Markers and CT Features in NSCLC
    Zhang, Hao
    He, Meng
    Wan, Ren'an
    Zhu, Liangming
    Chu, Xiangpeng
    [J]. JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
12345